Patient Information Leaflet
Barnidipine Swanpond Investments 20 mg prolonged-release hard capsules EFG
barnidipine hydrochloride
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The active substance of barnidipine belongs to a group of medicines called calcium antagonists. Barnidipine causes the blood vessels to dilate, which leads to a reduction in blood pressure. Barnidipine capsules are a prolonged-release form. This means that the active substance is absorbed gradually into the body and has a longer-lasting effect. This is why a daily dose is sufficient.
Barnidipine is used for the treatment of high blood pressure.
Do not take Barnidipine Swanpond Investments
Warnings and precautions
Consult your doctor or pharmacist before taking barnidipine
Children and adolescents
Barnidipine should not be used in children or adolescents under 18 years.
Other medicines and Barnidipine Swanpond Investments
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
It is especially important if you are using any of the following medicines, as they SHOULD NOT be used with barnidipine:
Also, inform your doctor if you are taking:
Taking Barnidipine Swanpond Investments with drinks and alcohol
Be careful when drinking alcohol or grapefruit juice as they may increase the effect of barnidipine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not take barnidipine during pregnancy unless clearly necessary.
You should not take barnidipine during breastfeeding. Barnidipine may pass into breast milk.
Driving and using machines
There is no information to suggest that barnidipine affects the ability to drive or use machines. However, as barnidipine may cause dizziness, you should know how this medicine affects you before driving or using machines.
Excipients:
This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Dosage
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, ask your doctor or pharmacist.
The recommended initial dose is 1 capsule of barnidipine 10 mg once a day. During treatment, your doctor may recommend increasing the dose to 1 capsule of barnidipine 20 mg once a day or 2 capsules of barnidipine 10 mg once a day.
If you are elderly, you can take the normal dose. Your doctor will probably monitor you closely at the beginning of treatment.
Instructions for proper use
If you take more Barnidipine Swanpond Investments than you should
If you have accidentally taken a large number of capsules at once, you should immediately consult your doctor or someone should take you to the emergency department. The possible symptoms of overdose include weakness, slowing or increased heart rate, drowsiness, confusion, nausea, vomiting, and convulsions.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Barnidipine Swanpond Investments
If you forget to take your dose of barnidipine at the usual time, take it as soon as possible on the same day. If more than 24 hours have passed, do not take a double dose to make up for the missed doses and continue with the usual schedule once a day.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience a severe allergic reaction that causes difficulty breathing or dizziness, you should inform your doctor or nurse immediately.
Barnidipine may cause:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Frequency not known: frequency cannot be estimated from the available data
These side effects tend to decrease or disappear during treatment (within a month for fluid accumulation and within two weeks for flushing, headache, and palpitations).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Barnidipine Swanpond Investments
Contents of the capsule:sugar spheres (contain sugar syrup, corn starch, and sucrose), carboxymethylcellulose, polysorbate 80, ethylcellulose, and talc.
Components of the capsule:titanium dioxide (E171), yellow iron oxide (E172), and gelatin.
Printing ink:shellac glazes, propylene glycol (E1520), black iron oxide (E172), and potassium hydroxide.
Appearance and pack contents
Hard gelatin capsules filled with yellow to pale yellow granules. The cap is yellow, marked with "1000" in black ink. Body yellow marked with "0020" in black ink.
Barnidipine Swanpond Investments prolonged-release hard capsules EFG are available in packs containing 28 and 56 capsules in OPA/Al/PVC-Aluminum blisters.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Swan Pond Investments Ltd
Landscape House
Baldonnell Business Park
Baldonnell,
Dublin,
D22 P3K7,
Ireland
Manufacturer
Balkanpharma-Dupnitsa AD
3, Samokovsko Shosse Str.
Dupnitza 2600
Bulgaria
Date of last revision of this leaflet:April 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/